Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04760639 · ClinicalTrials.gov registry record
COVID Breath Test - Ancon
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 100
- Enrollment target
NCT04760639 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 100 participants.
The verdict
NCT04760639 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.
Interventions
- DIAGNOSTIC_TEST Breath test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-16 |
| Est. Completion | 2022-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04760639
The ClinicalTrials.gov registry entry for NCT04760639 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breath test is the first listed.
NCT04760639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04760639 about?
NCT04760639 is a clinical study titled "COVID Breath Test - Ancon". This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by...
What is the current status of trial NCT04760639?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-12-16. Estimated completion is 2022-09-20.
What interventions are being tested in trial NCT04760639?
The interventions under investigation include: Breath test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04760639?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.